Findings

What do systematic reviews say?

3,696 questions · 3,815 findings · 855 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 573 · 15%GRADE not reported 374 · 9.8%Very low 993 · 26%Low 1,062 · 27.8%Moderate 614 · 16.1%High 199 · 5.2%

Standard valve vs self‐adjusting CSF flow‐regulating valve

Mortality Beyond the early postoperative period (> 30 days) · participants with hydrocephalus

1 finding from 1 review

Ventriculo‐peritoneal shunting devices for hydrocephalus 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 229 participants
Low

External differential programmable pressure valve vs non‐programmable valves

Mortality In the early postoperative period (≤ 30 days) · participants with hydrocephalus

The review found no eligible studies for this question.

1 finding from 1 review

Ventriculo‐peritoneal shunting devices for hydrocephalus 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

External differential programmable pressure valve vs non‐programmable valves

Mortality Beyond the early postoperative period (> 30 days) · participants with hydrocephalus

The review found no eligible studies for this question.

1 finding from 1 review

Ventriculo‐peritoneal shunting devices for hydrocephalus 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Standard valve vs anti‐syphon valve

Mortality In the early postoperative period (≤ 30 days) · participants with hydrocephalus

1 finding from 1 review

Ventriculo‐peritoneal shunting devices for hydrocephalus 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 229 participants
Low

Standard valve vs anti‐syphon valve

Mortality Beyond the early postoperative period (> 30 days) · participants with hydrocephalus

1 finding from 1 review

Ventriculo‐peritoneal shunting devices for hydrocephalus 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 229 participants
Low

Intervention not reported

Mortality In the early postoperative period (≤ 30 days) · participants with hydrocephalus

1 finding from 1 review

Ventriculo‐peritoneal shunting devices for hydrocephalus 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 174 participants
Very low

Intervention not reported

Mortality Beyond the early postoperative period (> 30 days) · participants with hydrocephalus

1 finding from 1 review

Ventriculo‐peritoneal shunting devices for hydrocephalus 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 90 participants
Very low

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 477 participants
High

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 673 participants
High

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
26 studies · 2035 participants
High

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 424 participants
High

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 759 participants
High

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
36 studies · 3847 participants
High

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 469 participants
High

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 777 participants
High

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
32 studies · 2789 participants
High

Hydrus microstent vs iStent trabecular micro‐bypass stent

Mean change in number of IOP‐lowering drops from baseline · people with open angle glaucoma, many of whom had mild or moderate glaucoma, which was well‐controlled with medication

1 finding from 1 review

Ab interno trabecular bypass surgery with Schlemm´s canal microstent (Hydrus) for open angle glaucoma 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 148 participants
Low

Cataract surgery with Hydrus microstent vs cataract surgery alone

Mean change in number of IOP‐lowering drops from baseline · people with cataracts and open angle glaucoma, many of whom had mild or moderate glaucoma, which was well‐controlled with medication

1 finding from 1 review

Ab interno trabecular bypass surgery with Schlemm´s canal microstent (Hydrus) for open angle glaucoma 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 619 participants
Low

Intervention not reported

Number of patients with all vascular events (stroke, MI, non‐fatal cardiac arrest, unstable angina requiring revascularisation, vascular death) at 90 days and at 1 year · patients with TIA or ischaemic stroke

The review found no eligible studies for this question.

1 finding from 1 review

Anti‐inflammatory therapy for preventing stroke and other vascular events after ischaemic stroke or transient… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Number of patients with recurrent stroke (fatal and non‐fatal) at 90 days and at 1 year · patients with TIA or ischaemic stroke

The review found no eligible studies for this question.

1 finding from 1 review

Anti‐inflammatory therapy for preventing stroke and other vascular events after ischaemic stroke or transient… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found